Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
ASX:NOX
Total Valuation
Noxopharm Ltd. has a market cap or net worth of AU$27.18M. The enterprise value is AU$16.71M.
Market CapAU$27.18M
Enterprise ValueAU$16.71M
Share Statistics
Noxopharm Ltd. has 292,237,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding292,237,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Noxopharm Ltd.’s return on equity (ROE) is -7.08 and return on invested capital (ROIC) is -127.80%.
Return on Equity (ROE)-7.08
Return on Assets (ROA)-1.07
Return on Invested Capital (ROIC)-127.80%
Return on Capital Employed (ROCE)-13.57
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.62
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Noxopharm Ltd. is ―. Noxopharm Ltd.’s PEG ratio is -0.09.
PE Ratio―
PS Ratio5.60
PB Ratio22.89
Price to Fair Value22.89
Price to FCF-2.71
Price to Operating Cash Flow-5.26
PEG Ratio-0.09
Income Statement
In the last 12 months, Noxopharm Ltd. had revenue of 2.82M and earned -4.88M in profits. Earnings per share was -0.02.
Revenue2.82M
Gross Profit-1.45M
Operating Income-9.65M
Pretax Income-4.88M
Net Income-4.88M
EBITDA-5.38M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -5.82M and capital expenditures 0.00, giving a free cash flow of -5.82M billion.
Operating Cash Flow-5.82M
Free Cash Flow-5.82M
Free Cash Flow per Share-0.02
Dividends & Yields
Noxopharm Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change-25.00%
50-Day Moving Average0.10
200-Day Moving Average0.08
Relative Strength Index (RSI)41.11
Average Volume (3m)123.50K
Important Dates
Noxopharm Ltd. upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
Noxopharm Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 359.32%
Current Ratio1.18
Quick Ratio1.18
Debt to Market Cap0.16
Net Debt to EBITDA-0.17
Interest Coverage Ratio-19.17
Taxes
In the past 12 months, Noxopharm Ltd. has paid -2.82M in taxes.
Income Tax-2.82M
Effective Tax Rate0.58
Enterprise Valuation
Noxopharm Ltd. EV to EBITDA ratio is -3.10, with an EV/FCF ratio of -2.87.
EV to Sales5.93
EV to EBITDA-3.10
EV to Free Cash Flow-2.87
EV to Operating Cash Flow-2.87
Balance Sheet
Noxopharm Ltd. has AU$1.55M in cash and marketable securities with AU$2.48M in debt, giving a net cash position of -AU$924.99K billion.
Cash & Marketable SecuritiesAU$1.55M
Total DebtAU$2.48M
Net Cash-AU$924.99K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is -51.25%, with operating margin of -342.14%, and net profit margin of -173.15%.
Gross Margin-51.25%
Operating Margin-342.14%
Pretax Margin-173.15%
Net Profit Margin-173.15%
EBITDA Margin-190.90%
EBIT Margin-190.96%
Analyst Forecast
The average price target for Noxopharm Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-36.89%